BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37846303)

  • 1. Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel.
    Bergantim R; Caetano A; Silva FF; Tavares I; Ferreira M; Jaime AR; Esteves GV
    Porto Biomed J; 2023; 8(5):e231. PubMed ID: 37846303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Bone Marrow Concentrate to Treat Pain and Musculoskeletal Disorders: An Academic Delphi Investigation.
    Centeno CJ; Jerome MA; Pastoriza SM; Shapiro S; Mautner K; Malanga GA; DePalma MJ; Mason RA; Stemper I; Dodson E
    Pain Physician; 2021 May; 24(3):263-273. PubMed ID: 33988946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of the elderly patient with AL amyloidosis.
    Nuvolone M; Milani P; Palladini G; Merlini G
    Eur J Intern Med; 2018 Dec; 58():48-56. PubMed ID: 29801808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis.
    ; Lousada I
    Orphanet J Rare Dis; 2020 Sep; 15(1):268. PubMed ID: 32993758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing oral corticosteroids in severe asthma (ROSA Project): a nationwide Portuguese consensus.
    Chaves Loureiro C; Branco Ferreira M; Ferreira J; Lima R; Marques J; Sokolova A; Tonin FS; Duarte Ramos F
    Pulmonology; 2021; 27(4):313-327. PubMed ID: 33177008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study.
    Isla D; Felip E; Garrido P; Insa A; Majem M; Remon J; Trigo JM; de Castro J
    Clin Transl Oncol; 2023 Jan; 25(1):283-291. PubMed ID: 36168085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of the consensus-based recommendations for Podiatry care of Neuropathy In Cancer Survivors (PodNICS): a Delphi consensus study of Australian podiatrists.
    Dars S; Buckley E; Beckmann K; Roder D; Banwell H
    J Foot Ankle Res; 2023 Jun; 16(1):33. PubMed ID: 37291602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
    Picken MM
    Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Awareness about Patient Blood Management in Portugal: A Call for Action Arising from a Delphi Panel.
    Robalo Nunes A; Brilhante D; Macedo A; Beato V; Gomes D; Gonçalves-Aguiar J; Lima F; Mairos J; Melo-Lencastre T
    Acta Med Port; 2022 Oct; 35(10):749-757. PubMed ID: 35633301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach.
    Hwa YL; Fogaren T; Sams A; Faller DV; Stull DM; Thuenemann S; Mendelson L
    J Adv Pract Oncol; 2019 Jul; 10(5):470-481. PubMed ID: 33457060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of AL amyloidosis in 2020.
    Palladini G; Milani P; Merlini G
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):363-371. PubMed ID: 33275753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatment.
    Lurie F; Malgor RD; Carman T; Dean SM; Iafrati MD; Khilnani NM; Labropoulos N; Maldonado TS; Mortimer P; O'Donnell TF; Raffetto JD; Rockson SG; Gasparis AP
    Phlebology; 2022 May; 37(4):252-266. PubMed ID: 35258350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in understanding and treating immunoglobulin light chain amyloidosis.
    Badar T; D'Souza A; Hari P
    F1000Res; 2018; 7():. PubMed ID: 30228867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of AL amyloidosis in 2020.
    Palladini G; Milani P; Merlini G
    Blood; 2020 Dec; 136(23):2620-2627. PubMed ID: 33270858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice.
    Louw VJ; Fraser I; Giraldo P
    PLoS One; 2023; 18(8):e0290401. PubMed ID: 37607165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.
    Olivieri I; Accorinti M; Abicca I; Bisceglia P; Cimino L; Latanza L; Leccese P; Lubrano E; Marchesoni A; Miserocchi E; Neri P; Salvarani C; Scarpa R; D'Angelo S;
    Rheumatol Int; 2018 Sep; 38(9):1727-1734. PubMed ID: 29961101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing and investigating children with suspected bone and abdominal tumours: an e-Delphi consensus process.
    Shanmugavadivel D; Liu JF; Gamble A; Polanco A; Vedhara K; Walker D; Ojha S
    BMJ Paediatr Open; 2023 Mar; 7(1):. PubMed ID: 36868779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.